California End of Life Option Act June 9, 2016 to present - - PowerPoint PPT Presentation

california end of life option act
SMART_READER_LITE
LIVE PREVIEW

California End of Life Option Act June 9, 2016 to present - - PowerPoint PPT Presentation

California End of Life Option Act June 9, 2016 to present California End of Life Option Act June 9, 2016 to present Bay Area End of Life Options Lonny Shavelson, M.D. BayAreaEndOfLifeOptions.com info@bayareaendoflifeoptions.com California


slide-1
SLIDE 1

California End of Life Option Act

June 9, 2016 to present

slide-2
SLIDE 2

Bay Area End of Life Options

Lonny Shavelson, M.D. BayAreaEndOfLifeOptions.com info@bayareaendoflifeoptions.com

California End of Life Option Act

June 9, 2016 to present

slide-3
SLIDE 3

Bay Area End of Life Options

Lonny Shavelson, M.D. Linda Spangler, M.D. Thalia DeWolf, R.N. – Hospice Nurse BayAreaEndOfLifeOptions.com info@bayareaendoflifeoptions.com

California End of Life Option Act

June 9, 2016 to present

slide-4
SLIDE 4

1996

slide-5
SLIDE 5

June 26, 1997

Unanimous decision that there is no constitutional right for physicians to help patients terminate their life.

slide-6
SLIDE 6

June 26, 1997 WASHINGTON, June 26, NY Times — Stepping for the first time into the wrenching political and moral debate over doctor-assisted suicide, the Supreme Court ruled today that states may continue to ban the practice but at the same time suggested that the

states were free to…permit doctor-assisted suicide if they chose to do so.

slide-7
SLIDE 7

7 states +Washington DC -- legalized Physician Aid in Dying 2018 2018

slide-8
SLIDE 8

7 states +Washington DC -- legalized Physician Aid in Dying 2018 20% of U.S. population has access to aid in dying. 2018

slide-9
SLIDE 9

California Hospital Association

slide-10
SLIDE 10

Step By Step Guide

slide-11
SLIDE 11

Who are the patients?

slide-12
SLIDE 12

Who are the patients?

  • 18 years or older
slide-13
SLIDE 13

Who are the patients?

  • 18 years or older
  • Terminally ill with a less-than six-month prognosis to live.
slide-14
SLIDE 14

Does being in hospice confirm the less than 6-month prognosis?

slide-15
SLIDE 15

JH: Hospice patient; 81-yr-old F with Progressive Supranuclear Palsy

Intake July 28: About 2 years before hospice admission, episodes

  • f balance difficulty and falling down.

The patient’s sxs have progressed since then, with progressive loss of muscle tone; she was last able to ambulate March. Her blurred vision progressed to horizontal diplopia; she now “can’t read, can barely see what’s on the TV.”

slide-16
SLIDE 16

JH: Progressive Supranuclear Palsy

Weight: Usual 135 Now 90 Mental status: oriented X 3, speech is slow but intelligible. General: Not able to ambulate. Can hold cup in hand herself and drink without spilling.

  • Physical Examination:
  • VS: P 81 R 12 BP 102/62 T O2 sat 97%

General: Sitting upright in chair with support. Frail, cachectic in appearance, feeble but audible voice. CHEST: Low volume, mild dry rales at both bases; she has some decreased bs at LLL posteriorly, possibly attributable to her hiatal hernia. MS: Alert, O X 3. Speech is halting.

slide-17
SLIDE 17

JH: Progressive Supranuclear Palsy

Reasons for considering physician aid-in-dying: She has thought for “as long as I can remember” that when she was near death “that I’d want to control it.” At the present time, she says she has nothing left to live for, “Nothing for me to look forward

  • to. I want to clean my house, do my gardening, read my books. I

can’t even see well enough to read any more.” She has thought carefully about wanting to die “since the illness got worse,” and says that she would “take the medication today if I could.”

slide-18
SLIDE 18

JH: Progressive Supranuclear Palsy

As the attending physician for the EOLOA, I confirmed the hospice prognosis of less than 6 months to live should the disease follow its expected course. Patient is a candidate for aid-in-dying.

slide-19
SLIDE 19

CS: Hospice patient; 92 yo F, Parkinson’s

Physical Examination: VS: P 73 R 14 BP 110/74 02 sat: 99% room air. Weight: not

  • btained

General: Pleasantly conversational. Not appearing cachectic. Sitting up in chair. Neuro: Alert, O X3, able to carry on complex conversation with full

  • understanding. Speech is full and not hesitant. Mild Parkinsonian tremor of

hands. Signs her name smoothly.

slide-20
SLIDE 20

CS: Parkinson’s

Nutritionist note. “Sitting up at bedside. Bkfst: ½ bowl

  • atmeal, scrambled eggs, 1 piece toast, 1 cup coffee.

Lunch: ½ bowl pasta, 1 bowl veg soup, coffee/dessert. Dinner: Salad, ½ bowl pasta, cup of tea, dessert.

slide-21
SLIDE 21

CS: Parkinson’s

Impression: While this patient is severely disabled, there is insufficient evidence that she has a less-than-6-month prognosis such that at this time I would write a prescription for an aid-in-dying medication.

slide-22
SLIDE 22

Why can the hospice prognosis be different than an aid-in-dying prognosis?

slide-23
SLIDE 23

If the hospice prognosis of less than six months to live is incorrect: The patient remains alive.

slide-24
SLIDE 24

If the hospice prognosis of less than six months to live is incorrect: The patient remains alive. If an aid-in-dying prognosis of less than six months to live is incorrect: The patient dies.

slide-25
SLIDE 25

The End of Life Option Act does not apply to people with severe disabilities who are not terminally ill with less-than six months to live.

slide-26
SLIDE 26

Who are the patients?

  • 18 years or older
  • Terminally ill with a six-month prognosis
  • Capable of making medical decisions
slide-27
SLIDE 27

EM: 65 yo M, liver cancer; cirrhosis.

Initial contact November 3 This 65 yo M has requested an evaluation for the End of Life Option Act…. However, he is leaving in 2 days with his wife for a “bucket list” trip to Costa Rica, to return in 8 days. In discussing this with the patient’s wife, I had some concern about his condition and the potential for it to deteriorate during his trip… He will contact me when he returns on 11/13/16. Home visit: 11/15/16; hep C followed by cirrhosis followed by hepatic cancer. Now, has 6- to 10-L paracentesis every 10 days.

slide-28
SLIDE 28

EM: Hepatic cancer; cirrhosis; CHF

I have expressed some concerns to the patient: He has an ICD/pacemaker, and this may complicate the course of his death after taking an AID medication. Risk of hepatic encephalopathy impairing his capacity to participate in EOLOA. I have strongly urged him to take his lactulose regularly. Given the patient’s intense desire not to have a prolonged course

  • f disability before his death, his care should emphasize prevention
  • f hepatic encephalopathy to maintain mental capacity.
slide-29
SLIDE 29

EM: Hepatic cancer; cirrhosis; CHF

January 20: Progression to hepatic encephalopathy. Wife cannot legally request medical aid in dying. But as his power of attorney, she does request full treatment of his hepatic encephalopathy so he can be coherent enough to tell her what to do.

slide-30
SLIDE 30

EM: Hepatic cancer; cirrhosis; CHF

January 20: Increase lactulose, add neomycin, start dexamethasone.

slide-31
SLIDE 31

EM: Hepatic cancer; cirrhosis; CHF

January 24: Home visit …awake, oriented, able to participate easily in complex

  • conversation. He sat in his backyard drinking a beer in the sun

and said he was “thrilled with a beautiful day.” He told me, as he had by phone in prior days, that he was glad to be alive and was feeling so good that he didn’t see any need at this time to think of an aid-in-dying medication.

slide-32
SLIDE 32

EM: Hepatic cancer; cirrhosis; CHF

IMP: XX has had an excellent recovery from his hepatic encephalopathy, back to the point where he could offer clear guidance to his wife and to me about his desire for AID. At this time, he would like to enjoy his relatively good health and continue all meds with the decrease noted above in dexamethasone dose…

He is still adamant about wanting AID if/when the time comes, i.e. when he is not as mobile or able to enjoy his life, and/or when his care creates a significant burden for his

  • wife. He understands that he may decline beyond

mental/physical capacity for an AID medication, in which case he would like aggressive comfort care and no further interventional treatment if he, in spite of the above meds, returns to hepatic encephalopathy.

slide-33
SLIDE 33

EM: Hepatic cancer; cirrhosis; CHF

February 13: Phone conversation with XX, patient’s wife. … was doing very well until 2 d ago when confusion

  • increased. He’s been consistent on his medications

including lactulose, neomycin and dexamethasone. He didn’t seem hyperactive but rather somewhat more lethargic than usual. In past 24 hours he’s become hallucinatory, angry, peeing on the floor, and confused. His wife is having a hard time managing him with this change. PLAN: Decrease dexamethasone; start haloperidol.

slide-34
SLIDE 34

EM: Hepatic cancer; cirrhosis; CHF

2/19/17: Phone call from patient, about noon, left message saying he’d like to talk with me. I called him back and he said that he was doing well again and thinking clearly and that he’d like to take AID medications tomorrow at noon.

slide-35
SLIDE 35

EM: Hepatic cancer; cirrhosis; CHF

February 19: Phone call from patient, about noon, left message saying he’d like to talk with me. I called him back and he said that he was doing well again and thinking clearly and that he’d like to take AID medications tomorrow at noon. February 20: Alert, oriented, coherent detailed

  • conversation. Takes aid-in-dying medications.
slide-36
SLIDE 36

Capacity is a moving target.

slide-37
SLIDE 37

Capacity is a moving target. You must continue to re-evaluate the patient while he/she waits for an aid-in-dying date.

slide-38
SLIDE 38

Who are the practitioners?

slide-39
SLIDE 39

Who are the practitioners?

ü Attending Physician: Has primary responsibility for the treatment of the individual’s terminal disease.

slide-40
SLIDE 40

Who are the practitioners?

ü Attending Physician: Has primary responsibility for the treatment of the individual’s terminal disease. ü “Independent” Consulting Physician: Qualified by specialty or experience to confirm (or deny) the diagnosis and prognosis.

slide-41
SLIDE 41

Who are the practitioners?

ü Attending Physician: Has primary responsibility for the treatment of the individual’s terminal disease. ü “Independent” Consulting Physician: Qualified by specialty or experience to evaluate the diagnosis and prognosis. ü Mental Health Specialist: (optional) Psychiatrist or Licensed Clinical Psychologist: Evaluates the patient’s “Capacity to make medical decisions.”

slide-42
SLIDE 42

Does depression disqualify the patient from the End of Life Option Act?

slide-43
SLIDE 43

“Capacity to make medical decisions”… the individual has the ability to understand the nature and consequences of a health care decision, the ability to understand its significant benefits, risks, and alternatives, and the ability to make and communicate an “informed decision”… (Probate Code Section 4609)

slide-44
SLIDE 44

JF: 64 yo F, multiple myeloma

My mental issues and distress play into this (lifelong history of depression, including attempted suicide). Am anxious and stressed

  • ut and not happy. My fear is that I’m producing less Hgb, getting

weaker, and I’m susceptible to infections. I’m not doing well now, and I’m only going to get worse.” Re Aid in dying: “It feels more humane and tolerable to set a time, to know what’s coming if it’s going to happen anyway. It seems comforting.”

slide-45
SLIDE 45

JF: 64 yo F, multiple myeloma

My mental issues and distress play into this (lifelong history of depression). Am anxious and stressed out and not happy. My fear is that I’m producing less Hgb, getting weaker, and I’m susceptible to infections. I’m not doing well now, and I’m only going to get worse.” “It feels more humane and tolerable to set a time, to know what’s coming if it’s going to happen anyway. It seems comforting.” Initial impression: depressed, but maintains capacity for medical decisions.

slide-46
SLIDE 46

JF: Multiple Myeloma

Hospice MD and staff note significant progression of depression. Repeat visit: “There’s no pleasure left any more and that’s a big reason I want to die.” “I’m really ashamed that it’s come to this. I never thought my life would end up this way.” “There’s no worse feeling in the world than being this depressed. I hate it. I can’t seem to pull myself out of this depression.” Readily agreed that her desire for AID at this time is mostly driven by her depression. “I have to find some way out of this depression.”

slide-47
SLIDE 47

JF: Multiple Myeloma

PE: makes no eye contact at all, mostly stares at a wall while

  • talking. Her speech is slow, hesitant.

…she had difficulty making decisions even while we were talking – she couldn’t decide what room we should talk in, whether I could talk with her family about her depression, whether she will take anti-depressant and/or energy-stimulant medications, all questions met with a vacant stare and the comment, “I don’t know, I’d have to think about that.” Her family related that she stared for hours in the morning trying to decide what socks to wear.

slide-48
SLIDE 48

JF: Multiple Myeloma

IMPRESSION: I explained to XX and her family that if she’s having such difficulty deciding which socks to put on in the morning, then her decision- making capacity is well below what would be needed to decide to take an aid-in-dying medication.

slide-49
SLIDE 49

How does it happen?

slide-50
SLIDE 50

How does it happen?

1) Verbal request #1: The patient makes a verbal request to the attending physician for an aid-in-dying medication. (NOTE: Obtain this first verbal request as early as possible. Do not wait – patients can get very ill very quickly and will die during the 15-day waiting period if you don’t start the clock ticking.) 2) Verbal request #2: The patient makes a second verbal request—at least 15 days after the first request. 3) Written request (witnessed): The patient fills out and signs CHA Form 5-5: “Request for an Aid-in-Dying Drug to End My Life in a Humane and Dignified Manner.” 4) Consult form filled out by 2nd physician (consulting).

slide-51
SLIDE 51

How does it happen?

1) Verbal request #1: The patient makes a verbal request to the attending physician for an aid-in-dying medication. (NOTE: Obtain this first verbal request as early as possible. Do not wait – patients can get very ill very quickly and will die during the 15-day waiting period if you don’t start the clock ticking.) 2) Verbal request #2: The patient makes a second verbal request—at least 15 days after the first request. 3) Written request (witnessed): The patient fills out and signs CHA Form 5-5: “Request for an Aid-in-Dying Drug to End My Life in a Humane and Dignified Manner.” 4) Consult form filled out by 2nd physician (consulting).

slide-52
SLIDE 52

How does it happen?

1) Verbal request #1: The patient makes a verbal request to the attending physician for an aid-in-dying medication. (NOTE: Obtain this first verbal request as early as possible. Do not wait – patients can get very ill very quickly and will die during the 15-day waiting period if you don’t start the clock ticking.) 2) Verbal request #2: The patient makes a second verbal request—at least 15 days after the first request. 3) Written request (witnessed): The patient fills out and signs CHA Form 5-5: “Request for an Aid-in-Dying Drug to End My Life in a Humane and Dignified Manner.” 4) Consult form filled out by 2nd physician (consulting).

slide-53
SLIDE 53

How does it happen?

1) Verbal request #1: The patient makes a verbal request to the attending physician for an aid-in-dying medication. (NOTE: Obtain this first verbal request as early as possible. Do not wait – patients can get very ill very quickly and will die during the 15-day waiting period if you don’t start the clock ticking.) 2) Verbal request #2: The patient makes a second verbal request—at least 15 days after the first request. 3) Written request (witnessed): The patient fills out and signs CHA Form 5-5: “Request for an Aid-in-Dying Drug to End My Life in a Humane and Dignified Manner.” 4) Consult form filled out by 2nd physician (consulting).

slide-54
SLIDE 54

Strongly recommended:

The attending physician informs the patient that: ü Another person should be present during ingestion of medication ü Next of kin should be informed

ü Participate in a hospice program

slide-55
SLIDE 55

EE: 76 yo M Bladder and colon cancer

Sept 3: bladder cancer followed by colon cancer X 2. Ileostomy/ureterostomy; repeated pelvic abscesses with drains, daily output >200cc, bloody. Repeated transfusions. Reasons for considering physician aid-in-dying: “I don’t want to die. It’s that I’m miserable, and I’ve been miserable for months now, and it’s not getting better and I’m not coping. I can’t walk anymore (pelvic pain and general weakness). I’m incredibly weak. I don’t enjoy anything any more. I’m deteriorating rapidly.” When would he choose to take AID medications: “Here, now.”

slide-56
SLIDE 56

EE: Bladder and colon cancer

PLAN: Continue abx. Enroll in hospice ASAP. Dexamethasone (risk of increased infection understood) for fatigue

slide-57
SLIDE 57

EE: Bladder and colon cancer

September 17: Phone conversation with patient at home: 5pm He’s doing remarkably well. He’s enrolled in hospice and has accepted some dexamethasone and says his energy and appetite have both improved substantially. He’s cautious about walking because of “balance problems” but says his mobility is still improved. His pelvic pain is well controlled – initially with a stormy roller coaster response to oxycodone, but now stabilized on methadone and prn oxycodone. He says his pain is now “quite comfortable.” He’s also using med marijuana and says it’s helping his appetite

  • substantially. He’s able to eat and drink.
slide-58
SLIDE 58

EE: Bladder and colon cancer

“When I last saw you I wanted the medication as soon as I could have it, but I’m feeling much better and just want it for later, in case I need it.”

slide-59
SLIDE 59

EE: Bladder and colon cancer

September 25: …his condition is deteriorating and he’s asking about AID meds: “I’m still not ready, but I want the medications to be available because it might be soon.”

slide-60
SLIDE 60

EE: Bladder and colon cancer

December 20: Aid-in-Dying day.

slide-61
SLIDE 61

How does EOLOA change hospice/palliative care

slide-62
SLIDE 62

JM: 95 yo F, heart failure

New onset of CHF from aortic stenosis. Hospitalized and “refused all treatment.” Discharged from hospital to hospice to “only treat my symptoms and let me die.”

slide-63
SLIDE 63

JM: Heart failure

Symptoms: …come on suddenly without warning, instantaneous

  • nset of profound SOB, chest tightness “like I can’t

breathe in or out,” followed by marked diaphoresis and uncontrollable shaking of her limbs. “I get to the point where I start crying, a complete breakdown.” Treatment: She receives MS and NTG and the sxs resolve over about 30 min. Frequency is increasing.

slide-64
SLIDE 64

JM: Heart failure

IMPRESSION: The patient’s major problem at this time is what appears clinically to be severe episodes of flash pulmonary edema. These have become extremely frightening and are one of her main (but not

  • nly) reasons for wanting a life-ending medication “as soon as I

can get it.” Fortunately, her paroxysmal dyspnea responds quickly to medications, but of course it would better to prevent rather than treat these episodes. Her CHF meds are minimalized by the patient’s request to “not treat” her CHF and possibly prolong her life.

slide-65
SLIDE 65

JM: Heart failure

Medications added: Isosorbide, carvedilol, increased furosemide, hs morphine.

slide-66
SLIDE 66

JM: Heart failure

Medications added: Isosorbide, carvedilol, increased furosemid, hs morphine. Two days later: Phone conversation with patient. She slept through the night last night, “it was wonderful,” without any SOB.

slide-67
SLIDE 67

JM: Heart failure

Medications added: Isosorbide, carvedilol, increased furosemide, hs morphine. Two days later: Phone conversation with patient. She slept through the night last night, “it was wonderful,” without any SOB. 15-days after first visit: No further episodes of shortness of breath. Takes Aid-in-Dying medications.

slide-68
SLIDE 68

Does everyone who gets a prescription use it?

slide-69
SLIDE 69

Does everyone who gets a prescription use it?

Oregon Death with Dignity Act: 1998 to 2016 data 1,749 prescriptions written after 15-day waiting period 1,127 deaths from ingesting the medications 622 families left with lethal medication after patient died

slide-70
SLIDE 70

Does everyone who gets a prescription use it?

Oregon: .% .%

slide-71
SLIDE 71

Does everyone who gets a prescription use it?

Oregon: 64% of dispensed medications taken. 36% of dispensed medications not taken. Bay Area End of Life Options: 95% of dispensed medications taken. 5% of dispensed medications not taken.

slide-72
SLIDE 72

Another reason not to dispense medications early

Patient X (not my patient): In hospice 63 yo F, colon cancer. Day 1: Makes 1st verbal request for AID. Patient in hospice. EOLOA attending physician external to hospice. Day 15: Makes 2nd verbal request to attending physician. Secobarbital prescribed and dispensed. Patient told by MD to ”take the medications when you’re ready.” Pharmacists provides detailed “how to” instructions.

slide-73
SLIDE 73

Another reason not to dispense medications early

Patient X (not my patient): 63 yo F, colon cancer. Day 1: Makes 1st verbal request for AID. Patient in hospice. EOLOA attending physician external to hospice. Day 15: Makes 2nd verbal request to attending physician. Secobarbital prescribed and dispensed. Patient told by MD to ”take the medications when you’re ready.” Pharmacists provides detailed “how to” instructions. Day 24: Intractable vomiting, early bowel obstruction. Vomiting improves, but unable to take much in p.o. Bowel sounds minimal, occasionally passing gas, some liquid stool.

slide-74
SLIDE 74

Another reason not to dispense medications early

Patient X (not my patient): 63 yo F, colon cancer. Day 1: Makes 1st verbal request for AID. Patient in hospice. EOLOA attending physician external to hospice. Day 15: Makes 2nd verbal request to attending physician. Secobarbital prescribed and dispensed. Patient told by MD to ”take the medications when you’re ready.” Pharmacists provides detailed “how to” instructions. Day 24: Intractable vomiting, early bowel obstruction. Vomiting improves, but unable to take much in p.o. Bowel sounds minimal, occasionally passing gas, some liquid stool. Day 26: Bowel sounds absent, not passing gas. Plans to take AID medications, says she will “force them down and keep them down.”

slide-75
SLIDE 75

Dying is a dynamic process.

slide-76
SLIDE 76

Dying is a dynamic process. Writing a prescription is a static moment.

slide-77
SLIDE 77

Dying is a dynamic process. Writing a prescription is a static moment. The Attending Physician for the EOLOA must continue to follow the patients as they approach death. (Working with hospice greatly aids this.)

slide-78
SLIDE 78

Dying is a dynamic process. Writing a prescription is a static moment. The Attending Physician for the EOLOA must continue to follow the patients as they approach death. (Working with hospice greatly aids this.) Patient care does not stop by writing an aid-in-dying prescription.

slide-79
SLIDE 79

The patient’s decision of when or if to take AID medications is a complicated anxiety-ridden process.

slide-80
SLIDE 80

The patient’s decision of when or if to take AID medications is a complicated anxiety-ridden process. The patient and family should not be left alone to figure this out without the attending physician’s involvement.

slide-81
SLIDE 81

How are the meds administered?

The medications must be “self-administered”: “…an affirmative, conscious, and physical act of administering and ingesting the aid-in-dying drug...”

slide-82
SLIDE 82

What are the medications?

slide-83
SLIDE 83

What are the medications?

The End of Life Option Act is silent as to which medications should be used.

slide-84
SLIDE 84

What are the medications?

Journal of Palliative Medicine Volume 18, Number X, 2015 DOI: 10.1089/jpm.2015.0092

Premedication antiemetic: Ondansetron 8mg + metoclopramide 20mg taken 45 to 60 minutes before. Secobarbital 100mg, #100 (=10gms). Mix powder from capsules with half-cup (4 oz) of water. Consume within 2 minutes.

slide-85
SLIDE 85

Secobarbital

Mechanism of action for aid-in-dying: 1) Rapidly after ingestion: Induces deep sleep

slide-86
SLIDE 86

Secobarbital

Mechanism of action for aid-in-dying: 1) Rapidly after ingestion: Induces deep sleep 2) Continued absorption: Sleep progresses to profound coma, essentially “anesthesia.”

slide-87
SLIDE 87

Secobarbital

Mechanism of action for aid-in-dying: 1) Rapidly after ingestion: Induces deep sleep 2) Continued absorption: Sleep progresses to profound coma, essentially “anesthesia.” 3) Coma deepens to the point where the brain stem no longer drives respiration.

slide-88
SLIDE 88

Secobarbital

Mechanism of action for aid-in-dying: 1) Rapidly after ingestion: Induces deep sleep 2) Continued absorption: Sleep progresses to profound coma, essentially “anesthesia.” 3) Coma deepens to the point where the brain stem no longer drives respiration. 4) Patient dies of respiratory arrest.

slide-89
SLIDE 89

Oregon 1998 to 2016: (almost uniformly, secobarbital) Time from ingestion of medication to death Median: 25 minutes Range: 1 minute to 104 hours (4.3 days)

slide-90
SLIDE 90

Oregon 1998 to 2016: (almost uniformly, secobarbital) Time from ingestion of medication to death Median: 25 minutes Range: 1 minute to 104 hours (4.3 days) Secobarbital reliably induces sleep and coma. It does not reliably stop respiration.

slide-91
SLIDE 91

June 9, 2016: California EOLOA begins

slide-92
SLIDE 92

June 9, 2016: California EOLOA begins

Price for secobarbital for AID: $3,500

slide-93
SLIDE 93

Alternate protocols

Developed by a 4-state task force: Washington, Vermont, Oregon, Montana.

Needs compounding pharmacist DDMP2 Diazepam 1gm (1,000mg) Morphine 15gm (15,000mg)

slide-94
SLIDE 94

Alternate protocols

Developed by a 4-state task force: Washington, Vermont, Oregon, Montana.

Needs compounding pharmacist DDMP2 Diazepam 1gm (1,000mg) Morphine 15gm (15,000mg) Medications for coma and respiratory suppression

slide-95
SLIDE 95

Alternate protocols

Developed by a 4-state task force: Washington, Vermont, Oregon, Montana.

Needs compounding pharmacist DDMP2 Diazepam 1gm (1,000mg) Morphine 15gm (15,000mg) Digitalis 50mg Propranolol 1gm (1,000mg)

slide-96
SLIDE 96

Alternate protocols

Developed by a 4-state task force: Washington, Vermont, Oregon, Montana.

Needs compounding pharmacist DDMP2 Diazepam 1gm (1,000mg) Morphine 15gm (15,000mg) Digitalis 50mg Propranolol 1gm (1,000mg) Two system protocol: If respiratory suppression by morphine and diazepam fails. Digitalis and propranolol will stop the heart.

slide-97
SLIDE 97

Mechanism of DDMP2 death

slide-98
SLIDE 98

BAEOLO data, to 8/20/2018: n=100 Time to death: Average: 2 hours Median: 43 minutes

Average: 1.8 hours Range: 7 minutes to 12 hours

slide-99
SLIDE 99

BAEOLO data, to 7/25/2018: n=92

Separating Digitalis from Other Medications (Free-dig)

slide-100
SLIDE 100

Bay Area End of Life Options To August, 2018 >800 inquiries about aid in dying

slide-101
SLIDE 101

Bay Area End of Life Options To July, 2018 >800 inquiries about aid in dying Patients accepted into BAELO 241

slide-102
SLIDE 102

Bay Area End of Life Options To July, 2018 >800 inquiries about aid in dying Patients accepted into BAELO 241 Aid-in-dying at bedside 100

slide-103
SLIDE 103

Range of our patients to 8/20/18: Bay Area and accessible Northern California

slide-104
SLIDE 104

Equivalent range for Scotland:

slide-105
SLIDE 105

Population Size (miles2) Deaths 2017 AID Deaths/total AID deaths California 40 million 164,000 277,000 1.35/100,000 374 Scotland 5.5 million 31,000 56,000 1.35/100,000 75

2017 Data: California and Scotland

slide-106
SLIDE 106

What have we learned from the first 2 years?

slide-107
SLIDE 107

What have we learned from the first 2 years?

  • It is extremely difficult for patients to access the

EOLOA with their own physicians.

slide-108
SLIDE 108

What have we learned from the first 2 years?

  • It is extremely difficult for patients to access the

EOLOA with their own physicians.

  • Dying is a dynamic, ever-changing process.

– Just “Writing the prescription” for the patient is not appropriate patient care. Following the patient over time is crucial.

slide-109
SLIDE 109

What have we learned from the first 1.5 years?

  • It is extremely difficult for patients to access the

EOLOA with their own physicians.

  • Dying is a dynamic, ever-changing process.

– Just “Writing the prescription” for the patient is not appropriate patient care. Following the patient over time is crucial.

  • Do not dispense AID medications until the patient is

ready to take them.

slide-110
SLIDE 110

What have we learned from the first 1.5 years?

  • It is extremely difficult for patients to access the

EOLOA with their own physicians.

  • Dying is a dynamic, ever-changing process.

– Just “Writing the prescription” for the patient is not appropriate patient care. Following the patient over time is crucial.

  • Do not dispense AID medications until the patient is

ready to take them.

  • Hospice care is essential for patients requesting aid in

dying.

slide-111
SLIDE 111

What have we learned from the first 1.5 years?

  • It is extremely difficult for patients to access the

EOLOA with their own physicians.

  • Dying is a dynamic, ever-changing process.

– Just “Writing the prescription” for the patient is not appropriate patient care. Following the patient over time is crucial.

  • Do not dispense AID medications until the patient is

ready to take them.

  • Hospice care is essential for patients requesting aid in

dying.

  • Hospice and the Attending Physician for the EOLOA

must tightly coordinate their care.

slide-112
SLIDE 112

What have we learned from the first 1.5 years?

  • It is extremely difficult for patients to access the

EOLOA with their own physicians.

  • Dying is a dynamic, ever-changing process.

– Just “Writing the prescription” for the patient is not appropriate patient care. Following the patient over time is crucial.

  • Do not dispense AID medications until the patient is

ready to take them.

  • Hospice care is essential for patients requesting aid in

dying.

  • Hospice and the Attending Physician for the EOLOA

must tightly coordinate their care.

  • Use medications that affect two vital systems:

Respiratory (through brain suppression) and Cardiac.

slide-113
SLIDE 113

What have we learned from the first 1.5 years?

  • It is extremely difficult for patients to access the

EOLOA with their own physicians.

  • Dying is a dynamic, ever-changing process.

– Just “Writing the prescription” for the patient is not appropriate patient care. Following the patient over time is crucial.

  • Do not dispense AID medications until the patient is

ready to take them.

  • Hospice care is essential for patients requesting aid in

dying.

  • Hospice and the Attending Physician for the EOLOA

must tightly coordinate their care.

  • Use medications that affect two vital systems:

Respiratory (through brain suppression) and Cardiac.

  • An experienced professional at the AID bedside is

crucial whenever possible.

slide-114
SLIDE 114

Bay Area End of Life Options

Lonny Shavelson, MD Linda Spangler, MD Thalia DeWolf, RN BayAreaEndOfLifeOptions.com info@bayareaendoflifeoptions.com (510) 423-0577